Patent details

EP1835911 Title: THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLAC

Basic Information

Publication number:
EP1835911
PCT Application Number:
PCT/US/2005/045883
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058545641
PCT Publication Number:
WO/2006/071601
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLAC
French Title of Invention:
COMPOSITIONS THERAPEUTIQUES SERVANT A ADMINISTRER KETOROLAC PAR VOIE NASALE
German Title of Invention:
THERAPEUTISCHE ZUSAMMENSETZUNGEN FÜR DIE INTRANASALE VERABREICHUNG VON KETOROLAC
SPC Number:

Dates

Filing date:
15/12/2005
Grant date:
29/08/2012
EP Publication Date:
29/08/2012
PCT Publication Date:
06/07/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/09/2007
EP B1 Publication Date:
29/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/12/2012
Expiration date:
15/12/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/12/2005
 
 

Name:
ROXRO Pharma Inc.
Address:
535 Middlefield Road, Suite 240, Menlo Park, CA 94025-3444, United States (US)

Inventor

1

Name:
THIRUCOTE Ramachandran
Address:
United States (US)

2

Name:
WHITING Roger
Address:
United States (US)

Priority

Priority Number:
639022 P
Priority Date:
23/12/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/407;
Filing date Document type Number of pages